×

img Accessibility Controls

Technologies Banner

All Technologies

An Herbal Based Composition for Treating (acute and chronic) Myeloid and Lymphoid Leukemia, Lymphomas

Project Overview

Treatment of acute and chronic myeloid leukemia, lymphoid leukemia and solid tumors including lymphomas.

Benefits

Specific killing of myeloid cancer cells and lymphoid cancer cells leaving other normal cells unaffected. Composition is administered through oral, intravenous, intramuscular or subcutaneous routes. Shorter treatment periods - Simplified method of extract preparation and purification of active ingredient from leaves or any other plant parts of Piper betel Small dose level ranging between 1 and 50 mg per kg body weight/day

Source

Quick Information
Thrust Areas
Medical Sciences
Focus Area
Treatment of Leukemia
Source Title
Output
TRL: Technology Readiness Level
Lab Validation
Patent
AU2001230492, CN1262289, DE10085492, GB2383753, JP5037778, US6852344, US7306817, US8029833, US7674487
arrowtop
Latest Updates
Loading…